Literature DB >> 3699894

Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.

A C Rodloff, J Becker, D K Blanchard, T W Klein, H Hahn, H Friedman.   

Abstract

A number of investigators have provided experimental evidence for synergistic effects in mixed infections with Escherichia coli and Bacteroides fragilis. In vitro studies have suggested that competition for serum opsonins and diminished subsequent phagocytosis by polymorphonuclear leukocytes might explain these effects. In the present study we evaluated the effect of B. fragilis on macrophage phagocytosis. It was shown that peritoneal macrophages from mice injected intravenously 6 to 12 h earlier with 10(8) CFU of encapsulated B. fragilis were markedly suppressed in their phagocytic ability. Injections of laboratory-passaged, less-encapsulated B. fragilis, other bacteria, or latex particles were either not suppressive of macrophage phagocytosis or less effective. When peritoneal macrophages were treated in vitro for 24 h with the same challenge organisms prior to assessing their phagocytic capacity, encapsulated B. fragilis also proved significantly more suppressive than challenges with other organisms or latex particles. We conclude that suppression of macrophage phagocytosis by B. fragilis seems to be an important mechanism contributing to synergistic effects described for mixed aerobic and anaerobic infections.

Entities:  

Mesh:

Year:  1986        PMID: 3699894      PMCID: PMC261025          DOI: 10.1128/iai.52.2.488-492.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.

Authors:  G L Spitalny
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

2.  Phagocytosis and killing of bacteria in aerobic and anaerobic conditions.

Authors:  H R Ingham; P R Sisson; R L Middleton; H K Narang; A A Codd; J B Selkon
Journal:  J Med Microbiol       Date:  1981-11       Impact factor: 2.472

3.  Effect of Bacteroides fragilis on the peritoneal clearance of Escherichia coli in mice.

Authors:  M Reznikov; J J Finlay-Jones; P J McDonald
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  Inhibition of phagocytosis in vitro by obligate anaerobes.

Authors:  H R Ingham; P R Sisson; D Tharagonnet; J B Selkon; A A Codd
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

5.  Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes.

Authors:  B A Dijkmans; P C Leijh; A G Braat; R van Furth
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.

Authors:  M J Kelly
Journal:  J Med Microbiol       Date:  1978-11       Impact factor: 2.472

8.  Thioglycolate medium decreases resistance to bacterial infection in mice.

Authors:  L A Baker; P A Campbell
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

Authors:  D L Kasper; A B Onderdonk; J Crabb; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

10.  Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.

Authors:  R W Tofte; P K Peterson; D Schmeling; J Bracke; Y Kim; P G Quie
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more
  3 in total

1.  Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.

Authors:  D K Blanchard; A C Rodloff; W E Steward; H Hahn; H Friedman
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 2.  Gut Bacteroides species in health and disease.

Authors:  Hassan Zafar; Milton H Saier
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.

Authors:  Sreedhar Subramanian; Carol L Roberts; C Anthony Hart; Helen M Martin; Steve W Edwards; Jonathan M Rhodes; Barry J Campbell
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.